Found 31 matching trials
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) PHASE2 The purpose of this study is to investigate the tolerability of ianalumab (...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
The Use of Eltrombopag Post HSCT in BMFD PHASE2 Bone marrow failure disease(BMFD) is a kind of bone marrow due to congenita...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Romiplostim for Oral TPO-RA Resistant ITP NA This study is a prospective, multicenter, open-label, single-arm cohort stu...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia PHASE2 This Phase II open-label interventional clinical trial aims to evaluate the...
Show More Location
University of Iowa Health Care
Learn More & Join Trial
Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia N/A The goal of this observational study is to characterize the diagnostic and ...
Show More Location
Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Learn More & Join Trial
The Safety and Efficacy Study of Avatrombopag Switch in TPO-RA Refractory AA NA This study was a single-arm, multicenter, phase Π clinical study. Patients ...
Show More Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia NA The primary objective of this trial is to assess the efficacy and safety of...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP) N/A Thrombopoietin Receptor Agonists (TPO-ra) are novel treatment modalities fo...
Show More Location
Copenhagen University Hospital Roskilde
Learn More & Join Trial
Romiplostim in Chemotherapy-Induced Thrombocytopenia PHASE3 Prospective interventional randomized controlled trial to assess safety and...
Show More Location
Ain Shams University Children's Hospital
Learn More & Join Trial
An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP N/A This is a multi-center, observational, Phase 4 study in patients with Immun...
Show More Location
Swedish Orphan Biovitrum Research Site 131
Learn More & Join Trial